Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Concurrent Plant-Based Ketogenic Diet and Intermittent Fasting (Ketoflex 12/3) on the Clinical Progression of Early-to-Mid Stage Alzheimer's Dementia

NCT06898424 is registered in ClinicalTrials.gov with Prof. Lutfu Hanoglu, MD as lead sponsor.

NCT NCT06898424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06898424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Concurrent Plant-Based Ketogenic Diet and Intermittent Fasting (Ketoflex 12/3) on the Clinical Progression of Early-to-Mid Stage Alzheimer's Dementia
Lead sponsor
Prof. Lutfu Hanoglu, MD
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2024
Completion date
October 31, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer type dementia, alzheimer's disease (ad)